Organon & Co | OGN - الدائنين التجاريين





الدائنين التجاريين تغيير تاريخ
Bristol-Myers Squibb USD 4.63B 470M 2026-09
Celltrion KRW 89.12B 534.9M 2026-06
Cspc Pharmaceutical CNY 2.32B 236.83M 2025-12
Deva Holding AS TRY 809.81M 105.88M 2023-09
Dianthus Therapeutics USD 5.5M 892K 2026-09
Divis Laboratories Ltd INR 12.11B 1.71B 2026-03
Gilead Sciences USD 934M 260M 2026-09
Glaxosmithkline GBP 15.63B 1.3B 2026-09
Kangmei Pharma CNY 2.27B 185.33M 2026-06
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Laboratorios Farma EUR 107.59M 341K 2023-12
Malin Corporation EUR 700K 200K 2024-12
Medical Developments International AUD 4.31M 2.18M 2025-12
Merck USD 5.03B 1.2B 2026-09
Neuren Pharmaceuticals AUD 2.4M 4.26M 2025-12
Novartis USD 4.24B 79M 2026-09
Organigram Holdings CAD 99.93M 26.79M 2026-06
Organon & Co USD 982M 69M 2026-09
Ovoca Bio EUR 1.3M 1.11M 2025-12
Pharma Mar EUR 50.62M 11.69M 2026-09
Qiagen NV USD 79.08M 785K 2026-06
Sartorius EUR 324.8M 4.3M 2026-09
Sino Biopharmaceutical CNY 2.82B 1.32B 2025-06
Tilray USD 114.5M 3.69M 2025-09
Zealand Pharma A/S 171M 175.6M 2026-03